Research Specifications
- Sequence:
- D-Arg-2',6'-Dmt-Lys-Phe-NH2
- CAS:
- 736992-21-5
- Molecular Weight:
- 639.79 Da
- Vial:
- 10mg lyophilized
- Purity:
- ≥98% HPLC verified
SS-31 10mg
Elamipretide cardiolipin-binding tetrapeptide
CAS: 736992-21-5
Cardiolipin
Primary target
Szeto 2014
Phase 3
Most advanced stage
Stealth BioTx
−70%
ROS reduction
Preclinical
Phase 3 trials (Stealth BioTherapeutics)
2024 FDA Complete Response Letter for Barth syndrome. Ongoing development in mitochondrial myopathy, LHON, and dry AMD. Not currently approved.
Complementary Compounds
Also Known As
Prep & Cycle Schedule
BAC Water
2mL
Final Concentration
5 mg/mL
Per Dose
5 mg = 1 mL · 10 mg = 2 mL (full vial)
Clinical trial label dose is 40mg/day — requires multiple vials
Published References
- 1.Szeto HH, Birk AV. Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Clinical Pharmacology & Therapeutics (2014) PMID: 24960521
- 2.Karaa A, Haas R, Goldstein A, et al.. Randomized dose-escalation trial of elamipretide in patients with primary mitochondrial myopathy. Neurology (2018) PMID: 29321236
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $89.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds
SS-31 25mg
SS-31 50mg
Thymulin 10mg
Epitalon 50mg
SS-31 10mg
$89.99